Synarel

PreclinicalSmall molecule

NNew Hope Fertility Center

Synarel is one of 4 small molecule programs targeting In Vitro Fertilization. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

In Vitro FertilizationCompleted

In Vitro FertilizationPreclinical

Completed

Competition

Competitive Landscape

3 competitors in In Vitro Fertilization

#DrugCompanyPhaseTrials

Clomid

Ferring

Preclinical

1 2

Gnrh-a

MMinia University

Preclinical

1 3

Menopur

Ferring

Preclinical

1 4

Synarel

NNew Hope Fertility Center

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

In Vitro Fertilization1 trial

Protocol to Minimize Injections and Blood Draws for Women Undergoing in Vitro Fertilization

Completed·NNew Hope Fertility Center·N/A·NCT02865681·4 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Synarel. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Synarel compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Synarel. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — New Hope Fertility Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: NNew Hope Fertility Center

Synarel

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

In Vitro Fertilization1 trial

References

Drug Info

Quick Facts

Related News